Junya Zhu

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. doi Comparative effectiveness of three platinum-doublet chemotherapy regimens in elderly patients with advanced non-small cell lung cancer
    Junya Zhu
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, MA 02215, USA
    Cancer 119:2048-60. 2013
  2. doi A longitudinal study of pain variability and its correlates in ambulatory patients with advanced stage cancer
    Junya Zhu
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, Massachusetts 02215 5450, USA
    Cancer 118:6278-86. 2012
  3. doi What constitutes patient safety culture in Chinese hospitals?
    Junya Zhu
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, MA 02215 5450, USA
    Int J Qual Health Care 24:250-7. 2012
  4. doi Can we rely on patients' reports of adverse events?
    Junya Zhu
    Center for Patient Safety, Dana Farber Cancer Institute, The Heller School for Social Policy and Management, Brandeis University, Boston, MA 02215 5450, USA
    Med Care 49:948-55. 2011
  5. doi Assessing the quality of pain care in ambulatory patients with advanced stage cancer
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, Massachusetts 02215, USA
    J Pain Symptom Manage 43:1072-81. 2012
  6. pmc Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancer
    Junya Zhu
    Center for Patient Safety, Dana Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA
    JAMA 307:1593-601. 2012
  7. pmc Hospitalized patients' participation and its impact on quality of care and patient safety
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, MA 02115, USA
    Int J Qual Health Care 23:269-77. 2011
  8. pmc US Cancer Center Implementation of ASCO/Oncology Nursing Society Chemotherapy Administration Safety Standards
    Saul N Weingart
    Dana Farber Cancer Institute, Boston, MA
    J Oncol Pract 8:7-12. 2012
  9. doi Comparative performance of community health centers and other usual sources of primary care
    Deborah Gurewich
    Schneider Institutes for Health Policy, Brandeis University, Waltham, MA, USA
    J Ambul Care Manage 34:380-90. 2011
  10. ncbi Identifying women at risk of delayed breast cancer diagnosis
    Sherri O Stuver
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, USA
    Jt Comm J Qual Patient Saf 37:568-75. 2011

Detail Information

Publications12

  1. doi Comparative effectiveness of three platinum-doublet chemotherapy regimens in elderly patients with advanced non-small cell lung cancer
    Junya Zhu
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, MA 02215, USA
    Cancer 119:2048-60. 2013
    ..Their relative effectiveness and comparability based on squamous versus nonsquamous histology is uncertain...
  2. doi A longitudinal study of pain variability and its correlates in ambulatory patients with advanced stage cancer
    Junya Zhu
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, Massachusetts 02215 5450, USA
    Cancer 118:6278-86. 2012
    ....
  3. doi What constitutes patient safety culture in Chinese hospitals?
    Junya Zhu
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, MA 02215 5450, USA
    Int J Qual Health Care 24:250-7. 2012
    ....
  4. doi Can we rely on patients' reports of adverse events?
    Junya Zhu
    Center for Patient Safety, Dana Farber Cancer Institute, The Heller School for Social Policy and Management, Brandeis University, Boston, MA 02215 5450, USA
    Med Care 49:948-55. 2011
    ..Evidence suggests that patients can report a variety of adverse events (AEs) not captured by traditional methods such as a chart review. Little is known, however, about whether patient reports are useful for measuring patient safety...
  5. doi Assessing the quality of pain care in ambulatory patients with advanced stage cancer
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, Massachusetts 02215, USA
    J Pain Symptom Manage 43:1072-81. 2012
    ..Pain is common among patients with advanced cancer despite the dissemination of clinical pain care guidelines...
  6. pmc Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancer
    Junya Zhu
    Center for Patient Safety, Dana Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA
    JAMA 307:1593-601. 2012
    ..However, longer survival was not observed in the subgroup of patients aged 65 years or older...
  7. pmc Hospitalized patients' participation and its impact on quality of care and patient safety
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, MA 02115, USA
    Int J Qual Health Care 23:269-77. 2011
    ..To understand the extent to which hospitalized patients participate in their care, and the association of patient participation with quality of care and patient safety...
  8. pmc US Cancer Center Implementation of ASCO/Oncology Nursing Society Chemotherapy Administration Safety Standards
    Saul N Weingart
    Dana Farber Cancer Institute, Boston, MA
    J Oncol Pract 8:7-12. 2012
    ..We sought to assess the implementation status of the ASCO/ONS chemotherapy administration safety standards...
  9. doi Comparative performance of community health centers and other usual sources of primary care
    Deborah Gurewich
    Schneider Institutes for Health Policy, Brandeis University, Waltham, MA, USA
    J Ambul Care Manage 34:380-90. 2011
    ..To determine how Community Health Centers (CHCs) perform relative to other primary care providers...
  10. ncbi Identifying women at risk of delayed breast cancer diagnosis
    Sherri O Stuver
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, USA
    Jt Comm J Qual Patient Saf 37:568-75. 2011
    ..Delays in breast cancer diagnosis contribute to increased morbidity and mortality. Factors related to the occurrence of delayed diagnosis have not been well studied...
  11. pmc Improving electronic oral chemotherapy prescription: can we build a safer system?
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA
    J Oncol Pract 8:e168-73. 2012
    ..We sought to describe the enhancement, examine its performance to date, and identify opportunities for improvement...
  12. ncbi The You CAN campaign: teamwork training for patients and families in ambulatory oncology
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, USA
    Jt Comm J Qual Patient Saf 35:63-71. 2009
    ..To examine the potential value of a patient-oriented teamwork intervention, a teamwork training initiative for oncology patients and their families was developed at the Dana-Farber Cancer Institute...